Canax logo — Società specializzata nello sviluppo di prodotti cosmeceutic...

Canax

Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica

Founded 2019 Italy Italy 4 employees Debt Financing Total: $2.50M Biotechnology, Health Care +1

General Information

Company Name Canax
Founded Year 2019
Location Italy Italy +2
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when Canax moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Canax

Canax is an Italian company specializing in extraction through supercritical CO2 and purification of compounds derived from cannabis. Founded in 2019, the company utilizes the most modern technologies and a deep understanding of the subject to extract 99.9x% pure isolated CBD for pharmaceutical, cosmetic, food, and veterinary use. The company's slogan "Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica" highlights its focus on the development of cosmeceutical and nutraceutical products with natural extracts through supercritical CO2 extraction. Canax operates in the Biotechnology, Health Care, and Pharmaceutical industries, with its headquarters based in Italy. Canax recently secured a €1.25M Debt Financing investment on 16 March 2022. The identity of the investors involved in the latest funding round is currently undisclosed. With its innovative approach to cannabis-derived compounds and the growing market demand for natural-based pharmaceutical and cosmetic products, Canax stands at the forefront of the industry. This recent investment further propels the company's potential for expansion and development in the health and wellness sector.

Taxonomy: CBD products, pharmaceutical industry, cosmeceutical industry, CO2 supercritical extraction, Cannabis extracts, pharmaceutical use, cosmetic use, veterinary use, CO2 extraction specialist, Cannabis-derived pharmaceuticals, Hemp extracts, plant-derived extracts, phytotherapeutic formulations, chemistry, supercritical CO2

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 16 Mar 2022
Seed Round •••••• - 03 Sep 2021

Canax Alternatives & Competitors

Canax vs

Sanoid produces medical cannabis extracts and isolates for medicinal, cosmetic, and pharmaceutical m...

2-10 employees
Health Care, Manufacturing
Canax vs
Brite Labs
Brite Labs United States

Clean and Authentic Cannabis.

17 employees
Health and Wellness
Canax vs
IGEA Pharma N.V.
IGEA Pharma N.V. The Netherlands

Harnessing the wealth of nature and innovative technologies to improve human health

Post Ipo Debt
2-10 employees
Biotechnology, Health Care

FAQ About Canax

Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica
Canax was founded in 2019.
Canax is headquartered in Italy.
Canax operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Canax has approximately 4 employees.
Canax has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Canax include Sanoid, Brite Labs, IGEA Pharma N.V., Má Botanics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Canax and Sanoid are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Canax and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy